NASDAQ:KRYS

Krystal Biotech Stock Predictions

etoro logo Buy KRYS
*Your capital is at risk
$301.82
+8.61 (+2.94%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

KRYS Prediction Chart

KRYS Predictions History

Latest community submissions for KRYS.
Predictor Target Session Target Price Result Direction Accuracy Score
May 7, 2024 $159.77 +1.80% $161.76 V 98.77% 2
May 7, 2024 $158.71 +1.13% $161.76 V 98.11% 1
Apr 29, 2024 $158.50 +1.03% $157.99 V 99.68% 5
Skagitqg Skagitqg Merchant
Apr 29, 2024 Bearish $157.99 X 0
May 25, 2023 $116.38 -1.81% $117.39 V 99.14% 3
May 25, 2023 $117.19 -1.13% $117.39 V 99.83% 6
May 25, 2023 Bullish $117.39 X 0
Dec 3, 2019 $60.17 +0.96% $59.60 X 99.04% 2
Dec 3, 2019 Bearish $59.60 X 1
JS JS Pro
Jul 8, 2019 $44.34 +4.87% $42.28 X 95.13% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for KRYS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT KRYSTAL BIOTECH INC
Krystal Biotech
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive con...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE